
Procter & Gamble Company (The) (NYSE:PG – Free Report) – Analysts at Erste Group Bank lowered their FY2027 earnings estimates for Procter & Gamble in a report released on Thursday, August 27th. Erste Group Bank analyst S. Lingnau now expects that the company will earn $6.98 per share for the year, down from their prior forecast of $7.00. The consensus estimate for Procter & Gamble’s current full-year earnings is $6.98 per share. Erste Group Bank also issued estimates for Procter & Gamble’s FY2028 earnings at $7.39 EPS.
PG has been the subject of several other reports. Jefferies Financial Group upped their target price on shares of Procter & Gamble from $177.00 to $179.00 and gave the company a “buy” rating in a research note on Friday, June 26th. Barclays upped their price objective on shares of Procter & Gamble from $146.00 to $152.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 21st. BMO Capital Markets lifted their target price on Procter & Gamble from $169.00 to $170.00 and gave the stock an “outperform” rating in a research report on Monday, June 29th. Weiss Ratings reiterated a “hold (c)” rating on shares of Procter & Gamble in a research report on Wednesday, June 24th. Finally, Bank of America decreased their price objective on Procter & Gamble from $170.00 to $166.00 and set a “buy” rating on the stock in a report on Friday, July 10th. Thirteen research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and a consensus price target of $161.19.
Procter & Gamble Stock Performance
PG opened at $145.51 on Monday. The company has a quick ratio of 0.47, a current ratio of 0.68 and a debt-to-equity ratio of 0.43. The stock’s 50 day moving average price is $147.06 and its two-hundred day moving average price is $148.12. The firm has a market capitalization of $338.23 billion, a P/E ratio of 21.98, a price-to-earnings-growth ratio of 4.43 and a beta of 0.39. Procter & Gamble has a 12-month low of $137.62 and a 12-month high of $167.25.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, topping the consensus estimate of $1.41 by $0.02. The company had revenue of $21.20 billion for the quarter, compared to analyst estimates of $21.38 billion. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. Procter & Gamble’s quarterly revenue was up 1.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.48 EPS. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS.
Procter & Gamble Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Monday, August 17th. Shareholders of record on Friday, July 24th were paid a dividend of $1.0885 per share. The ex-dividend date was Friday, July 24th. This represents a $4.35 dividend on an annualized basis and a yield of 3.0%. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.71%.
Insider Buying and Selling at Procter & Gamble
In related news, insider Susan Street Whaley sold 2,238 shares of the firm’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $143.79, for a total transaction of $321,802.02. Following the completion of the transaction, the insider owned 26,989 shares in the company, valued at $3,880,748.31. This trade represents a 7.66% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Marc S. Pritchard sold 4,030 shares of the company’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $143.79, for a total value of $579,473.70. Following the completion of the sale, the insider owned 187,001 shares in the company, valued at $26,888,873.79. This trade represents a 2.11% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 6,627 shares of company stock valued at $953,417. 0.20% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Procter & Gamble
Institutional investors and hedge funds have recently made changes to their positions in the company. Cornerstone Financial Management LLC grew its stake in Procter & Gamble by 43.5% during the second quarter. Cornerstone Financial Management LLC now owns 475 shares of the company’s stock worth $70,000 after buying an additional 144 shares during the last quarter. Tucker Asset Management LLC raised its holdings in shares of Procter & Gamble by 3.0% in the second quarter. Tucker Asset Management LLC now owns 7,061 shares of the company’s stock valued at $1,035,000 after buying an additional 203 shares during the last quarter. Amundi raised its holdings in shares of Procter & Gamble by 16.6% in the second quarter. Amundi now owns 10,679,775 shares of the company’s stock valued at $1,566,082,000 after buying an additional 1,519,268 shares during the last quarter. Wellington Grp LLC lifted its position in Procter & Gamble by 22.6% during the 2nd quarter. Wellington Grp LLC now owns 8,464 shares of the company’s stock worth $1,241,000 after buying an additional 1,562 shares in the last quarter. Finally, Brown Financial Advisors grew its holdings in Procter & Gamble by 2.5% during the 2nd quarter. Brown Financial Advisors now owns 22,274 shares of the company’s stock worth $3,266,000 after acquiring an additional 542 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
Key Headlines Impacting Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Several recent articles identify PG as a leading dividend stock for 2027 and beyond, emphasizing its dependable income, long record of dividend growth and resilience across economic cycles. This supports demand from income-oriented and defensive investors. The Best Dividend Stock for 2027 and Beyond: Procter & Gamble
- Positive Sentiment: PG is being presented as an attractive alternative to simply owning the Consumer Staples Select Sector SPDR Fund (XLP), reflecting investor interest in selecting high-quality individual dividend payers with established household brands. These 3 Dividend Stocks Make a Strong Case for Skipping XLP
- Neutral Sentiment: The bullish investment case also depends on productivity improvements, new product innovation and robust cash returns. Those factors could help offset modest underlying growth, although PG’s valuation remains relatively rich. Is P&G Stock Worth Buying as Growth Slows and Valuation Stays Rich?
- Negative Sentiment: Analysts highlight an estimated 8% fiscal 2027 core EPS headwind from higher input costs, financing expenses, lower non-operating income and unfavorable currency movements. These pressures could limit earnings growth and weigh on the stock’s premium valuation. P&G Fiscal 2027 Outlook Brings an 8% Core EPS Headwind Into Focus
- Negative Sentiment: Erste Group Bank issued a bearish forecast for PG’s fiscal 2027 earnings, reinforcing concerns that the company’s near-term fundamentals may not justify its valuation. Erste Group Bank Has Bearish Forecast for PG FY2027 Earnings
About Procter & Gamble
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
